Estimating the extent of vaccine-derived poliovirus infection.
about
Emergence and re-emergence of viral diseases of the central nervous system.Making Common Sense of Vaccines: An Example of Discussing the Recombinant Attenuated Salmonella Vaccine with the PublicFrom emergence to eradication: the epidemiology of poliomyelitis deconstructedCharacterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population.Mechanisms controlling virulence thresholds of mixed viral populations.Quantifying the impact of expanded age group campaigns for polio eradicationFeasibility of quantitative environmental surveillance in poliovirus eradication strategies.Detection of imported wild polioviruses and of vaccine-derived polioviruses by environmental surveillance in EgyptAn Insight into Recombination with Enterovirus Species C and Nucleotide G-480 Reversion from the Viewpoint of Neurovirulence of Vaccine-Derived Polioviruses.Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern NigeriaInactivated polio vaccine: its proposed role in the final stages of polio eradication.Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).Antigenic breadth: a missing ingredient in HSV-2 subunit vaccines?Vaccine-derived polioviruses.Wild and vaccine-derived poliovirus circulation, and implications for polio eradication.Phenotypic and genomic analysis of serotype 3 Sabin poliovirus vaccine produced in MRC-5 cell substrate.The risk of type 2 oral polio vaccine use in post-cessation outbreak response.Detection of vaccine-derived polioviruses in Mexico using environmental surveillance.Genetic analysis of poliovirus strains isolated from sewage in Poland.The Importance of Trust in the Vaccine Safety Enterprise.100 years poliovirus: from discovery to eradication. A meeting report.
P2860
Q33812013-6978F490-2F4C-4BE3-8632-008CA36B905AQ34030095-B0E30054-B4DC-4576-B2C4-53734F4AEC7FQ34349482-9C9C9C6F-F166-4EEA-8469-3661E2EC9128Q34632088-19BB70C0-55CD-459B-9F55-2874428F232EQ34743352-574895FC-6A06-42C7-80EE-034D2589E080Q35382314-CBD048B4-603E-4C79-BEE0-875D7404E242Q35463044-F84BF19D-E0C7-464E-A2DA-DFC2D5BFDFC5Q35940966-BCBF790D-EB2B-4993-8BD3-41CF7B2B9563Q36155857-8B799A11-79A5-42DD-9A52-9D761F0ABA36Q36316673-E95B4B75-518D-4418-80D8-8F803C88B44BQ36760045-18FAE093-29A2-415F-B989-ECB49855F4FCQ36878782-31121798-ED6E-4B56-82F6-AAF9541E4D7DQ38028997-FC3AAE6D-E501-4CFF-B682-0C12CAB1E69CQ38087428-B448BA58-CB75-4420-B0EA-7556A760C5B2Q38212516-6AA7A0C1-5E6B-45D0-9C84-BD3F39DFDCA5Q38260375-2337C072-2223-48B5-BFC6-9AF042EAC91BQ39014586-45EBDF70-A6D8-405C-A6C7-F38795078710Q39574954-D066BAC2-5F16-4ADC-9C32-4D640113B6F4Q41925239-2C1B0AE7-41C3-4B3E-A515-855A8F16F758Q42183593-3A20CDAB-E88F-436B-9EB1-457B8A814B95Q42262657-B9692840-C0EF-49C3-A8D1-2D1446D654BDQ46794581-BDB0E4BE-89CA-4A20-9200-4F91C503622AQ54196020-185BBAF3-E97C-4B07-950C-FD8727B07A01
P2860
Estimating the extent of vaccine-derived poliovirus infection.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Estimating the extent of vaccine-derived poliovirus infection.
@ast
Estimating the extent of vaccine-derived poliovirus infection.
@en
type
label
Estimating the extent of vaccine-derived poliovirus infection.
@ast
Estimating the extent of vaccine-derived poliovirus infection.
@en
prefLabel
Estimating the extent of vaccine-derived poliovirus infection.
@ast
Estimating the extent of vaccine-derived poliovirus infection.
@en
P2093
P2860
P1433
P1476
Estimating the extent of vaccine-derived poliovirus infection.
@en
P2093
Olen M Kew
Paul E M Fine
Roland W Sutter
P2860
P356
10.1371/JOURNAL.PONE.0003433
P407
P577
2008-10-29T00:00:00Z